PRLD - Prelude Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

PRLD is currently covered by 4 analysts with an average price target of $4.47. This is a potential upside of $0.4 (9.83%) from yesterday's end of day stock price of $4.07.

Prelude Therapeutics 's activity chart (see below) currently has 16 price targets and 25 ratings on display. The stock rating distribution of PRLD is 58.33% BUY, 33.33% HOLD and 8.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 34.64% with an average time for these price targets to be met of 103.25 days.

Highest price target for PRLD is $5, Lowest price target is $4, average price target is $4.47.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 20-Feb-2024. First documented stock forecast 20-Oct-2020.

Best performing analysts who are covering PRLD - Prelude Therapeutics :

Robert Burns Tazeen Ahmad Jeffrey Hung Peter Lawson

Currently out of the existing stock ratings of PRLD, 7 are a BUY (58.33%), 4 are a HOLD (33.33%), 1 are a SELL (8.33%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

5

$1.13 (29.20%)

5

2 months 9 days ago

2/8 (25%)

$0.84 (20.19%)

104

Sell

4

$0.13 (3.36%)

10

4 months 10 days ago

2/7 (28.57%)

$-0.04 (-0.99%)

4

5

$1.13 (29.20%)

12

8 months 25 days ago

1/4 (25%)

$1.33 (36.24%)

251

Hold

6

$2.13 (55.04%)

10

1 years 5 months 8 days ago

3/5 (60%)

$-0.53 (-8.12%)

54

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRLD (Prelude Therapeutics ) average time for price targets to be met?

On average it took 103.25 days on average for the stock forecasts to be realized with a an average price target met ratio 34.64

Which analyst has the current highest performing score on PRLD (Prelude Therapeutics ) with a proven track record?

ROBERT BURNS

Which analyst has the current lower performing score on PRLD (Prelude Therapeutics ) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on PRLD (Prelude Therapeutics )?

Robert Burns has 13 price targets and 10 ratings on PRLD

Which analyst is the currently most bullish on PRLD (Prelude Therapeutics )?

Tazeen Ahmad with highest potential upside - $2.13

Which analyst is the currently most reserved on PRLD (Prelude Therapeutics )?

Jeffrey Hung with lowest potential downside - $0.13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?